Total: $1,163.86M

Company
(Symbol)#

Type Of
Financing

Number
Of
Shares,
Units
Or
Warrants
(M)

Amount
Raised
(M)

Investors; Placement Agents; Details
(Date)@


Aastrom
Biosciences
Inc.
(ASTM)

Private
placement
of common
stock

1.88S

$2.95

Aastrom raised $2.95M in private placements with Isosceles Fund Ltd., Radyr Group Investments and Rochelle S.A. (6/26)

AtheroGenics
Inc.
(AGIX)

Private
placement of
common stock

3.6S

$20.6

AtheroGenics raised $20.6M through the sale of 3.6M shares; JPMorgan H&Q acted as placement agent; investors included SAFECO Growth Opportunities Fund and Vulcan Ventures Inc. (6/20)

Bioniche Life
Sciences Inc.
(Canada; TSE:BNC)

Private
placement of
special warrants

N/A

C$6
(US$3.97)

Bioniche completed the first tranche in a private placement of special warrants (6/29)

Biopure Corp.
(BPUR)

Equity line
agreement

N/A

_

Biopure entered a $75M equity line stock purchase agreement with the Parisian bank Societe Generale that gives the company the option to draw funds over the next two years (6/22)

BioTransplant
Inc.
(BTRN)

Private
placement of
common stock

3S

$19

BioTransplant raised $19M, placing 3M shares with institutional investors (6/7)

Cellegy
Pharmaceuticals
Inc.
(CLGY)

Private
placement of
common stock

2.7S

$15.4

Cellegy raised $15.4M through the placement of 2.7M shares with investors Baker/Tisch Investments, GMT Capital Corp., OrbiMed Advisors, SAFECO Asset Management, First Manhattan Co., JALAA Equities and Knott Partners (6/8)

Cell
Therapeutics
Inc.
(CTIC)

Private
placement of
convertible
subordinated
notes

N/A

$150

Cell Therapeutics raised $150M through the placement; each note will convert to common stock at an initial conversion price of $34 per share (6/8)

Cephalon Inc.
(CEPH)

Private
placement of
convertible
subordinated
notes

N/A

$100

Cephalon's purchasers of its $300M aggregate principal amount of 5.52% convertible subordinated notes due 2006 have exercised in full their option to purchase $100M in additional notes (6/21)

COR
Therapeutics
Inc.
(CORR)

Private
placement of
convertible
senior notes

N/A

$250

COR agreed to sell $250M of five-year senior notes to institutional buyers (6/6)

Cytogen Corp.
(CYTO)

Private
placement of
common stock

1.82S

$8.19

Cytogen placed 1.82M shares with the State of Wisconsin Investment Board at $4.50 per share, raising $8.19M (6/19)

DepoMed Inc.
(AMEX:DMI)

Private
placement of
shares and
warrants

2.9S and

1.5W

$12.3

DepoMed raised $12.3M with the placement of 2.9M shares and 1.5M warrants; investors were Easton Hunt Capital Partners LP and OrbiMed Advisors LLC, as well as S Squared Technology Corp. and Special Situations Funds; Fahnestock and Co. Inc. acted as placement agent (6/14)

DNAPrint
genomics Inc.
(OTC BB:DNAP)

Growth
capital funding

N/A

$2

Tampa Bay Financial committed to an additional $2M in growth capital (6/18)

Gliatech Inc.
(GLIA)

Equity
financing
agreement

N/A

$2.5

Gliatech received an additional $2.5M under its agreement with Paul Capital Royalty Acquisition Fund LP (6/27)

Enzon Inc.
(ENZN)

Private
placement of
convertible
subordinated
notes

N/A

$400

Enzon plans to offer convertible subordinated notes worth $400M; the notes will be convertible into shares of Enzon stock; an overallotment option to issue an additional $60M in notes also may be exercised (6/14)

Guilford
Pharmaceuticals
Inc.
(GLFD)

Private
placement of
common stock

3S

$59

Guilford raised $59M with the private placement of 3M shares with selected institutional investors, at a purchase price of $19.70 per share; CIBC World Markets Corp. served as placement agent (6/12)

InKine
Pharmaceutical
Co.
(INKP)

Private
placement of
convertible
subordinated
notes

N/A

$10

InKine raised $10M from a private placement of 5.5% convertible subordinated notes due June 2003, along with warrants, with SAC Capital and SDS Capital Partners (6/18)

Matritech Inc.
(NMPS)

Private
placement of
common stock

0.33S

$1.08

Matritech sold 331,256 shares to Acqua Wellington North American Equities Fund Ltd. (6/4)

Novogen Ltd.
(Australia; NVGN)

Private
placement of
common stock

10.5S

$11.2

Novogen raised $11.2M with the issuance of 10.5M shares (6/1)

Orchid
BioSciences
Inc.
(ORCH)

Private
placement of
common stock

5.95S

$35.7

Orchid sold 5.95M shares in a private placement; Robertson Stephens Inc. served as the placement agent and First Union Securities was co-placement agent; the financing was pursuant to a shelf registration filed in May (6/13)

Ortec
International
Inc.
(ORTC)

Non-equity
financing

N/A

_

Ortec signed a letter of intent with the Paul Capital Royalty Acquisition Fund for $25M of non-equity capital based on the achievement of milestones (6/29)

Procyon
BioPharma Inc.
(Canada; TSE:PBP)

Private
placement of
common stock

N/A

C$1
(US
$0.66)

Procyon completed the private placement with NATCAN and SIPAR (6/26)

SangStat Inc.
(SANG)

Private
placement of
common stock

1.36S

$15

SangStat completed a private placement raising $15M through the sale of 1.36M shares to institutional investors at $11 per share (6/22)

Sonus
Pharmaceuticals
Inc.
(SNUS)

Private
placement of
common stock

1.7S

$4.9

Sonus grossed $4.9M through a private placement of 1.7M shares with investors Orion Biomedical Fund, OrbiMed Advisors LLC and Perceptive Life Sciences Funds; Evolution Capital served as placement agent (6/18)

Synsorb
Biotech Inc.
(Canada; SYBB;
TSE:SYB)

Equity line
agreement

1S

_

Equity line agreement in which Synsorb may sell up to 1M shares of Oncolytics Biotech Inc. to Roseworth Group LLC over a 12-month period (6/1)

Theratechnologies
Inc.
(Canada;
TSE:TH)

Private
placement of
common stock

N/A

C$60
(US
$39.41)

Theratechnologies raised C$60M in a financing with Societe Generale de Financement de Quebec and the Solidarity Fund QFL (6/22)


Notes:

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

N/A = Not available or reported.

AMEX = American Stock Exchange; CDNX = Canadian Venture Exchange; OTC BB = Over the Counter Bulletin Board; TSE = Toronto Stock Exchange

No Comments